Literature DB >> 8605095

Biological activity of the receptor for macrophage colony-stimulating factor in the human endometrial cancer cell line, Ishikawa.

S Takeda1, W P Soutter, N J Dibb, J O White.   

Abstract

Previously we found that the Ishikawa endometrial cancer cell line expresses macrophage colony-stimulating factor (M-CSF) and c-fms transcripts and that its proliferation is enhanced by the addition of recombinant M-CSF. This suggested that Ishikawa cells are constitutively stimulated by M-CSF. In support of this we now show that Ishikawa cells secrete M-CSF and that known stimulators of M-CSF production increase the amount detected in Ishikawa cell conditioned medium. Using retroviral infections to introduce and express exogenous c-fms genes in Ishikawa cells we also demonstrate proliferation to be partially inhibited by a dominant negative, mutant c-fms gene, yet enhanced approximately 3-fold by a normal c-fms gene, under conditions in which the only source of M-CSF was that produced by the cells. The data provide evidence for the existence of an active M-CSF/receptor loop in these endometrial cancer cells and suggests the possibility of such activity in tumours of the endometrium and ovary that aberrantly express M-CSF and fms genes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8605095      PMCID: PMC2074351          DOI: 10.1038/bjc.1996.106

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  34 in total

Review 1.  Lymphohematopoietic cytokines in the female reproductive tract.

Authors:  J W Pollard
Journal:  Curr Opin Immunol       Date:  1991-10       Impact factor: 7.486

2.  Expression of v-fms and c-fms in the hemopoietic cell line FDC-P1.

Authors:  N J Dibb; S M Green; P Ralph
Journal:  Growth Factors       Date:  1990       Impact factor: 2.511

3.  A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization.

Authors:  O Kashles; Y Yarden; R Fischer; A Ullrich; J Schlessinger
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

4.  The cytokine CSF-1 (M-CSF) expressed by endometrial carcinomas in vivo and in vitro, may also be a circulating tumor marker of neoplastic disease activity in endometrial carcinoma patients.

Authors:  B M Kacinski; S K Chambers; E R Stanley; D Carter; P Tseng; K A Scata; D H Chang; M H Pirro; J T Nguyen; A Ariza
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-09       Impact factor: 7.038

5.  Temporal expression and location of colony-stimulating factor 1 (CSF-1) and its receptor in the female reproductive tract are consistent with CSF-1-regulated placental development.

Authors:  R J Arceci; F Shanahan; E R Stanley; J W Pollard
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

6.  Expression of the colony-stimulating factor-1 receptor (c-fms proto-oncogene product) in the human uterus and placenta.

Authors:  S Pampfer; E Daiter; D Barad; J W Pollard
Journal:  Biol Reprod       Date:  1992-01       Impact factor: 4.285

7.  Involvement of a nuclear factor-kappa B-like protein in induction of the macrophage colony-stimulating factor gene by tumor necrosis factor.

Authors:  H Yamada; S Iwase; M Mohri; D Kufe
Journal:  Blood       Date:  1991-10-15       Impact factor: 22.113

8.  Expression of the macrophage colony-stimulating factor and its receptor in gynecologic malignancies.

Authors:  G Baiocchi; J J Kavanagh; M Talpaz; J T Wharton; J U Gutterman; R Kurzrock
Journal:  Cancer       Date:  1991-02-15       Impact factor: 6.860

9.  Ligand and protein kinase C downmodulate the colony-stimulating factor 1 receptor by independent mechanisms.

Authors:  J R Downing; M F Roussel; C J Sherr
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 4.272

10.  Colony-stimulating factor-1 and c-fms expression in human endometrial tissues and placenta during the menstrual cycle and early pregnancy.

Authors:  S W Kauma; S L Aukerman; D Eierman; T Turner
Journal:  J Clin Endocrinol Metab       Date:  1991-10       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.